Suchergebnisse - "Ziepert, Marita"

PubPharm (13)

1

FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : results from the prospective, multicenter PETAL and OPTIMAL>60 trials

enthalten in: European journal of nuclear medicine and molecular imaging | 2021

von Kaddu-Mulindwa, D. | Altmann, B. | Held, G. | +16

2

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER) : a randomised, phase 3, non-inferiority trial

enthalten in: Lancet (London, England) | 2019

von Poeschel, V. | Held, G. | Ziepert, M. | +43

CommentIn: Lancet. 2020 Dec 21;394(10216):2208-2209. - PMID 31868615

3

Doubling rituximab in high-risk patients with aggressive B-cell lymphoma -results of the DENSE-R-MegaCHOEP trial

enthalten in: British journal of haematology | 2019

von Friedrichs, B. | Nickelsen, M. | Ziepert, M. | +12

4

Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

enthalten in: Nature medicine | 2018

von Chapuy, B. | Stewart, C. | Dunford, A. | +43

ErratumIn: Nat Med. 2018 Aug;24(8):1292. - PMID 29955181

5

Optimization of rituximab for the treatment of DLBCL : increasing the dose for elderly male patients

enthalten in: British journal of haematology | 2017

von Pfreundschuh, M. | Murawski, N. | Zeynalova, S. | +16

6

Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2017

von Staiger, A. | Ziepert, M. | Horn, H. | +21

7

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

enthalten in: Blood | 2016

von Mansouri, L. | Noerenberg, D. | Young, E. | +52

CommentIn: Blood. 2016 Dec 8;128(23 ):2591-2592. - PMID 27932324

8

Modified BEAM with triple autologous stem cell transplantation for patients with relapsed aggressive non-Hodgkin lymphoma

enthalten in: Annals of hematology | 2016

von Hohloch, K. | Zeynalova, S. | Chapuy, B. | +8

9

Vitamin D deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B-cell lymphoma treated with but not without rituximab

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2014

von Bittenbring, J. | Neumann, F. | Altmann, B. | +7

10

The role of radiotherapy and intrathecal CNS prophylaxis in extralymphatic craniofacial aggressive B-cell lymphomas

enthalten in: Blood | 2014

von Murawski, N. | Held, G. | Ziepert, M. | +12